Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Interim Review

5 Jun 2006 15:44

Ark Therapeutics Group PLC05 June 2006 Ark Therapeutics Group plc 5 June 2006 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Ark Therapeutics Group plc 2. Name of scheme Ark Therapeutics Group Unapproved Share Option Scheme (the "Scheme") 3. Period of return From 3/12/2005 to 2/6/2006 4. Number and class of shares(s) (amount of stock/debt security) not issued under the Scheme 907,401 ordinary shares of 1 pence each 5. Number of shares issued/allotted under the Scheme during period 36,250 6. Balance under the Scheme not yet issued/allotted at end of period 871,151 7. Number and class of share(s) (amount of stock/debt securities) originally listed and the date of admission 126,220,994 ordinary shares admitted to listing on 8/3/2004 Please confirm total number of shares in issue at the end of the period in order for us to update our records: 159,372,573 Contact for queries: Nick Plummer, Ark Therapeutics Group plc, 79 New Cavendish Street, London W1W 6XBTelephone: 0207 388 7722 Person making return:Name: Nick PlummerPosition: Company Secretary Ark Therapeutics Group plc 5 June 2006 SCHEDULE 5 BLOCKLISTING SIX MONTHLY RETURN 1. Name of company Ark Therapeutics Group plc 2. Name of scheme Ark Therapeutics Group Enterprise Management Incentive Share Option Plan (the "Scheme") 3. Period of return From 3/12/2005 to 2/6/2006 4. Number and class of shares(s) amount of stock/debt security) not issued under the Scheme 277,016 ordinary shares of 1 pence each 5. Number of shares issued/allotted under the Scheme during period Nil 6. Balance under the Scheme not yet issued/allotted at end of period 277,016 7. Number and class of share(s) (amount of stock/debt securities) originally listed and the date of admission 126,220,994 ordinary shares admitted to listing on 8/3/2004 Please confirm total number of shares in issue at the end of the period in order for us to update our records: 159,372,573 Contact for queries: Nick Plummer, Ark Therapeutics Group plc, 79 New Cavendish Street, London W1W 6XBTelephone: 0207 388 7722 Person making return:Name: Nick PlummerPosition: Company Secretary This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
19th May 20087:00 amRNSResearch Update
16th May 20087:00 amRNSInterim Management Statement
24th Apr 20084:57 pmRNSAGM Results
22nd Apr 20087:00 amRNSRegulatory Update
17th Apr 20087:00 amRNSProduct Update
1st Apr 20083:26 pmRNSAnnual Information Update
31st Mar 200812:39 pmRNSTotal Voting Rights
28th Mar 20081:46 pmRNSRe Appointment
20th Mar 20087:00 amRNSBoard Appointment
11th Mar 20087:01 amRNSLaunch of Neuropad
11th Mar 20087:01 amRNSFinal Results
5th Mar 20085:20 pmRNSHolding(s) in Company
13th Feb 20087:00 amRNSManufacturing Update
31st Jan 200810:27 amRNSVoting Rights and Capital
23rd Jan 20084:56 pmRNSNotice of Results
18th Jan 20087:01 amRNSResearch Update
17th Jan 200810:42 amRNSRe: Employee Benefit Trust
11th Jan 200810:33 amRNSDirector/PDMR Shareholding
9th Jan 20084:50 pmRNSResignation of NED
8th Jan 20087:00 amRNSAcquisition
19th Dec 20074:37 pmRNSPrice Monitoring Extension
6th Dec 20075:48 pmRNSHolding(s) in Company
5th Dec 20071:39 pmRNSHolding(s) in Company
5th Dec 200712:41 pmRNSHolding(s) in Company
4th Dec 20075:40 pmRNSBlocklisting Interim Review
4th Dec 20074:56 pmRNSBlocklisting Interim Review
4th Dec 200711:50 amRNSHolding(s) in Company
30th Nov 200712:35 pmRNSDirector/PDMR Shareholding
30th Nov 200712:10 pmRNSVoting Rights and Capital
29th Nov 20072:17 pmRNSResult of EGM
28th Nov 20074:27 pmRNSRe: Placing and Open Offer
6th Nov 20077:01 amRNSPlacing and Open Offer
30th Oct 20075:08 pmRNSHolding(s) in Company
25th Oct 20077:01 amRNSResearch Update
22nd Oct 20071:01 pmRNSHolding(s) in Company
16th Oct 20073:23 pmRNSHolding(s) in Company
10th Oct 20077:01 amRNSRe Agreement
8th Oct 20077:00 amRNSRe Agreement
28th Sep 20073:06 pmRNSVoting Rights and Capital
31st Aug 200710:39 amRNSVoting Rights and Capital
29th Aug 20077:01 amRNSInterim Results
20th Aug 20077:02 amRNSRe: Product Launch
31st Jul 200711:23 amRNSVoting Rights and Capital
26th Jul 20077:01 amRNSResearch Update
24th Jul 200711:18 amRNSNotice of Results
23rd Jul 20077:01 amRNSRe: Cerepro
6th Jul 20077:00 amRNSEPO Grant Stroke Patent
29th Jun 20071:14 pmRNSVoting Rights and Capital
22nd Jun 20074:03 pmRNSHolding(s) in Company
15th Jun 20072:45 pmRNSDirector's Share Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.